112305 ⎘
Vector systems having a special element relevant for transcription from viruses
TISSUE SPECIFIC SYNTHETIC PROMOTERS AND CIRCUITS AND USE THEREOF
#2LENTIVIRAL VECTORS AND USES THEREOF
#3Replicon Compositions and Methods of Using Same for the Treatment of Diseases
#4ARCHAEAL PYRROLYSYL TRNA SYNTHETASES FOR ORTHOGONAL USE
#5TAT-INDUCED CRISPR/ENDONUCLEASE-BASED GENE EDITING
#6VERO CELL LINES STABLY EXPRESSING HSV ICP0 PROTEIN
#7MATERIALS AND METHODS FOR THE TREATMENT OF EIF2B5 MUTATIONS AND DISEASES RESULTING THEREFROM
#8NON-INTEGRATING VIRAL DELIVERY SYSTEM AND METHODS RELATED THERETO
#9INTRON FRAGMENTS
#10PLASMID FOR PRODUCTION OF RECOMBINANT PROTEIN IN MAMMALIAN CELL
#11SINGLE-VECTOR GENE CONSTRUCT COMPRISING INSULIN AND GLUCOKINASE GENES
#12DNA Amplification Method Using CARE Elements
#13NON-INTEGRATING VIRAL DELIVERY SYSTEM AND METHODS RELATED THERETO
#14ADENOVIRUS ARMED WITH BISPECIFIC T CELL ACTIVATOR
#15COMPOSITIONS AND METHODS FOR PRODUCTION OF CIRCULAR NUCLEIC ACID MOLECULES
#16BCMA CHIMERIC ANTIGEN RECEPTORS
#17CIRCULAR RNA AND PREPARATION METHOD THEREOF
#18MANUFACTURING METHOD OF ADENO-ASSOCIATED VIRUS, CELL, AND EXPRESSION VECTOR
#19NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING PFIC THERAPEUTICS
#20Adenovirus armed with bispecific T cell activator
#21TRANSPOSON-BASED VECTORS AND USES
#22COMPOSITIONS AND METHODS FOR INHIBITING ALPHA-SYNUCLEIN AGGREGATION
#23Modified Marek's disease virus, and vaccines made therefrom
#24GENETICALLY STABLE RECOMBINANT MODIFIED VACCINIA ANKARA (RMVA) VACCINES AND METHODS OF PREPARATION THEREOF
#25TAT-INDUCED CRISPR/ENDONUCLEASE-BASED GENE EDITING
#26LIVER-SPECIFIC CONSTRUCTS, FACTOR VIII EXPRESSION CASSETTES AND METHODS OF USE THEREOF
#27COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING CORONAVIRUS INFECTIONS
#28GEMINIVIRAL VECTORS THAT REDUCE CELL DEATH AND ENHANCE EXPRESSION OF BIOPHARMACEUTICAL PROTEINS
#29COMPOSITIONS AND PRODUCTION OF NICKED CLOSED-ENDED DNA VECTORS
#30GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC GENES
#31Intron fragments
#32Potent and short promoter for expression of heterologous genes
#33Expression from transposon-based vectors and uses
#34Nucleic acids encoding Zika virus-like particles and their use in Zika virus vaccines and diagnostic assays
#35ENGINEERED UBIQUITOUS CHROMATIN OPENING ELEMENTS AND USES THEREOF
#36CANCER IMAGING WITH THERAPY: THERANOSTICS
#37PSMA-based molecular-genetic reporter system
#38Genetically stable recombinant modified vaccinia Ankara (rMVA) vaccines and methods of preparation thereof
#39Strong insulator and uses thereof in gene delivery
#40Adenovirus armed with bispecific T cell activator
#41Gene expression system using stealthy RNA, and gene introduction/expression vector including said RNA
#42Single-vector gene construct comprising insulin and glucokinase genes
#43Vero cell lines stably expressing HSV ICP0 protein
#44Gene expression system using stealthy RNA, and gene introduction/expression vector including said RNA
#45STABLE CELL LINES FOR RETROVIRAL PRODUCTION
#46Stable cell lines for retroviral production
#47BCMA chimeric antigen receptors
#48IL-12 IMMUNOTHERAPY FOR CANCER
#49EXPRESSION VECTORS COMPRISING CHIMERIC CYTOMEGALOVIRUS PROMOTER AND ENHANCER SEQUENCES
#50CMV PROMOTER AND METHOD FOR PRODUCTION OF POLYPEPTIDES
#51ORTHOGONAL TRANSCRIPTIONAL SWITCHES DERIVED FROM TET REPRESSOR HOMOLOGS FOR SACCHAROMYCES CEREVISIAE
#52Promoter with an enriched Cytosine-Guanine dinucleotide region, vectors, cellular lines, method for producing recombinant protein
#53CHIMERIC POST-TRANSCRIPTIONAL REGULATORY ELEMENT
#54Nucleic acids encoding zika virus-like particles and their use in zika virus vaccines and diagnostic assays
#55Non-integrating viral delivery system and methods related thereto
#56NEGATIVE SELECTION AND STRINGENCY MODULATION IN CONTINUOUS EVOLUTION SYSTEMS
#57NON-INTEGRATING VIRAL DELIVERY SYSTEM AND METHODS RELATED THERETO
#58Adenovirus armed with bispecific T cell engager
#59Modified Marek's disease virus, and vaccines made therefrom
#60Oncolytic group B adenovirus expressing a stroma-targeted bispecific t-cell engager
#61Expression from transposon-based vectors and uses
#62Liver-specific constructs factor VIII expression cassettes and methods of use thereof
#63Liver-specific constructs and methods of use thereof
#64Immunomodulatory Oncolytic Adenoviral Vectors, and Methods of Production and Use Thereof for Treatment of Cancer
#65LENTIVIRAL TRIPLEX DNA, AND VECTORS AND RECOMBINANT CELLS CONTAINING LENTIVIRAL TRIPLEX DNA
#66Vectors and host cells comprising a modified SV40 promoter for protein expression
#67Turkey herpesvirus vectored recombinant containing avian influenza genes
#68LENTIVIRAL TRIPLEX DNA, AND VECTORS AND RECOMBINANT CELLS CONTAINING LENTIVIRAL TRIPLEX DNA
#69LENTIVIRAL VECTORS AND USES THEREOF
#70STABLE CELL LINES FOR RETROVIRAL PRODUCTION
#71Method for expression of small RNA molecules within a cell
#72Potent and short promoter for expression of heterologous genes
#73IMPROVED NEGATIVE-STRAND RNA VIRAL VECTOR
#74Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for treatment of cancer
#75ARMED REPLICATION-COMPETENT ONCOLYTIC ADENOVIRUSES
#76Promoters for expression of heterologous genes
#77PR13.5 promoter for robust T-cell and antibody responses
#78NUCLEIC ACID CONSTRUCT FOR EXPRESSING MORE THAN ONE CHIMERIC ANTIGEN RECEPTOR
#79Canine adenovirus vectors
#80TAT-INDUCED CRISPR/ENDONUCLEASE-BASED GENE EDITING
#81Single-vector gene construct comprising insulin and glucokinase genes
#82Gene expression system using stealthy RNA, and gene introduction/expression vector including said RNA
#83Expression vectors comprising chimeric cytomegalovirus promoter and enhancer sequences
#84NON-VIRAL IPSCS INDUCING COMPOSITION AND KITS
#85HVT-vectored ND-IBD vaccine
#86Virus-based expression vectors and uses thereof
#87Turkey herpesvirus vectored recombinant containing avian influenza genes
#88Genetically stable recombinant modified vaccinia ankara (rMVA) vaccines and methods of preparation thereof
#89Nucleic acid vector
#90PSMA-based molecular-genetic reporter system
#91STABLE CELL LINES FOR RETROVIRAL PRODUCTION
#92Splice variants of GDNF and uses thereof
#93Promoters for high level expression
#94Chimeric post-transcriptional regulatory element
#95CMV promoter and method for production of polypeptides
#96Vectors and methods for the efficient generation of integration/transgene-free induced pluripotent stem cells from peripheral blood cells
#97Synthetic genes and genetic constructs
#98Expression vector for expressing heterogeneous gene
#99Vectors and host cells comprising a modified SV40 promoter for protein expression
#100Dual-color HIV reporter system for the detection of latently-infected cells
#101IL-12 immunotherapy for cancer
#102Proviral plasmids and production of recombinant adeno-associated virus
#103Compositions and methods of use thereof for identifying anti-viral agents
#104Expression vector
#105Pr13.5 promoter for robust T-cell and antibody responses
#106Enhanced nucleic acid constructs for eukaryotic gene expression
#107Enhanced nucleic acid constructs for eukaryotic gene expression
#108Retroviral vector with mini-promoter cassette
#109Methods and compositions for regulation of zinc finger protein expression
#110Oncolytic measles virus
#111Baculoviral DNA elements for the expression of recombinant proteins in a host insect
#112Expression vectors comprising chimeric cytomegalovirus promoter and enhancer sequences
#113Increasing protein yield in plants
#114TRANSGENIC NON-HUMAN ANIMAL AND USES THEREOF
#115Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
#116Poxviral vectors for low antibody response after a first priming immunization
#117Method for expression of small RNA molecules within a cell
#118CHO expression system
#119Transcription units and the use thereof in expression vectors
#120Viral vector construct for neuron specific optimized continuous DOPA synthesis in vivo
#121Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy
#122Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy
#123LENTIVIRAL VECTORS AND USES THEREOF
#124Baculovirus-based vaccines
#125Alphavirus vectors for respiratory pathogen vaccines
#126Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
#127Compositions and methods for generating an immune response
#128Control of gene expression
#129Genetically stable recombinant modified vaccinia ankara (rMVA) vaccines and methods of preparation thereof
#130Hybrid promoter and recombinant vector comprising the same
#131Synthetic genes and genetic constructs
#132Herpesvirus of turkeys vectored vaccine against avian influenza in poultry
#133Oncolytic measles virus
#134Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy
#135Novel viral vector construct for neuron specific optimized continuous DOPA synthesis in vivo
#136CONTROL OF GENE EXPRESSION
#137Transgenic non-human animal and uses thereof
#138ENHANCER FOR PROMOTER, AND USE THEREOF
#139PRODUCTION OF AN INTACT VIRUS IN A MAMMALIAN (NON-HOST) CELL SYSTEM USING A SECONDARY NON-HOST VIRAL CONSTRUCT
#140Promote system for regulatable gene expression in mammalian cells
#141Synthetic genes and genetic constructs
#142Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
#143Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
#144Polynucleotides encoding a human TRIM-Cyp fusion polypeptide, compositions thereof, and methods of using same
#145CHROMOSOME-BASED PLATFORMS
#146NON-AD5 ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO
#147METHODS AND COMPOSITIONS FOR INHIBITING PROPAGATION OF VIRUSES USING RECOMBINANT TETHERIN CONSTRUCTS
#148COMPOSITIONS AND METHODS OF USE OF TARGETING PEPTIDES FOR DIAGNOSIS AND THERAPY OF HUMAN CANCER
#149Attentuated Herpesvirus Encoding a Mek Pathway Polypeptide
#150Method of expression of foreign gene in plant induced by chemical substance
#151VIRAL NUCLEOCAPSID PROTEIN AS A MULTIFUNCTIONAL TRANSLATION INITIATION FACTOR AND INCREASED PROTEIN AND POLYPEPTIDE PRODUCTION USING SAME
#152Bovine immunodeficiency virus (BIV) based vectors
#153MVA expressing modified HIV envelope, GAG, and POL genes
#154LENTIVIRUS-BASED IMMUNOGENIC VECTORS
#155MVA expressing modified HIV envelope, gag, and pol genes
#156HISTONE OCTAMERS FOR INCREASED NUCLEIC ACID TRANSFER
#157VV PROMOTER-DRIVEN OVEREXPRESSION OF RECOMBINANT ANTIGENS
#158Method for expression of small RNA molecules within a cell
#159STEM CELL EXPRESSION CASSETTES
#160Expression vectors comprising the mCMV IE2 promoter
#161Use of MVA to treat prostate cancer
#162Methods for treating cancer with a recombinant MVA expressing HER-2
#163Alphavirus Vectors for Respiratory Pathogen Vaccines
#164Genetically stable recombinant modified vaccinia ankara (rMVA) vaccines and methods of preparation thereof
#165Splice variants of GDNF and uses thereof
#166Generation of Genetically Corrected Disease-free Induced Pluripotent Stem Cells
#167IL-12 immunotherapy for cancer
#168Baculovirus-Based Vaccines
#169ENHANCED HOMOLOGOUS RECOMBINATION MEDIATED BY LAMBDA RECOMBINATION PROTEINS
#170Optimized early-late promoter combined with repeated vaccination favors cytotoxic T cell response against recombinant antigen in MVA vaccines
#171Isolated Polynucleotide Sequence with IRES Activity
#172NUCLEIC ACID CONSTRUCTS
#173PLASMID CONTAINING A SEQUENCE ENCODING A DISINTEGRIN DOMAIN OF METARGIDIN (RDD)
#174Eukaryotic layered vector initiation systems
#175Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
#176TARGETED TUMOR THERAPY BY USE OF RECOMBINANT ADENOVIRUS VECTORS THAT SELECTIVELY REPLICATE IN HYPOXIC REGIONS OF TUMORS
#177Purkinje cell-tropic viral vector
#178Turkey herpesvirus vectored recombinant containing avian influenza genes
#179Novel Vectors for Production of Interferon
#180Promoter for introducing a gene into a lymphocyte or blood cell and application thereof
#181CELL LINES WITH LATENT IMMUNODEFICIENCY VIRUS AND METHODS OF USE THEREOF
#182Expression system incorporating a capsid promoter sequence as an enhancer
#183HYBRID ADENO-RETROVIRAL VECTOR FOR THE TRANSFECTION OF CELLS
#184Promoter for introducing a gene into a lymphocyte or blood cell and application thereof
#185Promoter for introducing a gene into a lymphocyte or blood cell and application thereof
#186GENE EXPRESSION SYSTEM USING ALTERNATIVE SPLICING IN INSECTS
#187Recombinant protein production in a human cell
#188VACCINIA VIRUS HOST RANGE GENES TO INCREASE THE TITER OF AVIPOXVIRUSES
#189Humanised Baculovirus
#190Alphavirus Vectors for Respiratory Pathogen Vaccines
#191Use of MVA to treat prostate cancer
#192Bovine immunodeficiency virus (BIV) based vectors
#193MVA expressing modified HIV envelope, gag, and pol genes
#194Non-invasive localization of a light-emitting conjugate in a mammal
#195Stocks of replication-deficient adenovirus
#196Dengue Reporter Virus and Methods of Making and Using the Same
#197Replication competent hepatitis C virus and methods of use
#198Recombinant protein production in a human cell
#199Live virus vaccines
#200Turkey herpesvirus vectored recombinant containing avian influenza genes
#201Non-invasive localization of a light-emitting conjugate in a mammal
#202Methods for treating cancer with a recombinant MVA expressing HER-2
#203Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genes
#204Nucleic acid constructs
#205Protein isolation
#206Lentiviral LTR-deleted vector
#207Regulation of oncogenesis by Akt-specific isoforms
#208Method for the identification of compounds capable of activating latent human immunodeficiency virus (HIV)
#209New Expression Tools for Multiprotein Applications
#210Method for expression of small antiviral RNA molecules within a cell
#211Expression vectors comprising the mCMV IE2 promoter
#212Gene Construction, Vector and Dna Vaccine for the Vaccination of Aquatic Animals
#213Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
#214Bovine immunodeficiency virus (BIV) based vectors
#215GM-CSF gene therapy for Crohn's disease using an improved regulated expression system
#216HUMAN DISEASE MODELING USING SOMATIC GENE TRANSFER
#217Insulated herpesvirus-derived gene expression cassettes for sustained and regulatable gene expression
#218Sequences upstream of the carp gene, vectors containing them and uses thereof
#219Adenovirus packaging cell lines
#220Truncated CMV promoters and vectors containing same
#221hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes
#222Isolated polynucleotide sequence with IRES activity
#223Recombinant protein production in a human cell
#224Method of making a genetically modified mammalian cell
#225HYBRID VECTOR HAVING A CYTOMEGALOVIRUS ENHANCER AND MYELOPROLIFERATIVE SARCOMA VIRUS PROMOTER
#226Treatment of disease using an improved regulated expression system
#227Modulation of cytokine signaling regulators and applications for immunotherapy
#228Chromosome-based platforms
#229Adiponectin gene therapy
#230Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof
#231Lentiviral LTR-deleted vector
#232Gene trap system
#233Recombinant poxvirus comprising at least two compox ATI promoters
#234High yield heterologous expression cell lines for expression of gene products with human glycosylation pattern
#235Method of expressing gene in transgenic birds using retrovirus vector and transgenic birds thus obtained
#236Transduction vector based on modified HIV-2
#237MVA expressing modified HIV envelope, gag, and pol genes
#238Episomal expression system
#239Sequences upstream of the CARP gene, vectors containing them and uses thereof
#240Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors
#241Recombinant expression of factor VIII in human cells
#242Flavivirus expression and delivery system
#243Tissue specific expression of exogenous proteins in transgenic chickens
#244Isolated avian cell that expresses Vaccinia virus host range genes
#245Hybrid adeno-retroviral vector for the transfection of cells
#246Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
#247Adenovirus packaging cell lines
#248Chromosome-based platforms
#249Lentiviral vectors and uses thereof
#250Bovine immunodeficiency virus (BIV) based vectors
#251Control of gene expression
#252Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
#253Non-invasive localization of a light-emitting conjugate in a mammal
#254Nucleic acid constructs for gene expression
#255Control of gene expression
#256Lentiviral LTR-deleted vector
#257Non-invasive localization of a light-emitting conjugate in a mammal
#258Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer
#259Recombinant negative strand virus RNA expression systems and vaccines
#260Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
#261Bovine immunodeficiency virus (BIV) based vectors
#262Poxvirus with targeted infection specificity
#263Cytomegalovirus Intron A fragments
#264Chromosome-based platforms
#265Recombinant protein production in permanent amniocytic cells that comprise nucleic acid encoding adenovirus E1A and E1B proteins
#266Replication competent hepatitis C virus and methods of use
#267Bovine immunodeficiency virus (BIV) based vectors
#268Bovine immunodeficiency virus (BIV) based vectors
#269Efficient production of IgA in recombinant mammalian cells
#270Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
#271Cytomegalovirus Intron A fragments
#272Packaging systems for human recombinant adenovirus to be used in gene therapy
#273Dna construct for assessing thymic function activity and therapeutical uses thereof
#274Protein isolation
#275Promoters to control cell differentiation
#276Inducible protein expression system
#277Enzymatically active recombinant glucocerebrosidase
#278Use of chimeric nucleases to stimulate gene targeting
#279Enzymatically active recombinant glucocerebrosidase
#280Marek's disease virus vaccine
#281Sequences upstream of the carp gene, vectors containing them and uses thereof
#282Adenovirus packaging cell lines
#283Adenoviral E1A/E1B complementing cell line
#284Gene delivery system and methods of use
#285Attenuated protein expression vectors and associated methods
#286In vitro transcription methods and constructs